Drug Price Transparency in Medicaid Act of 2021
Summary
Drug Price Transparency in Medicaid Act of 2021 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
Bill status
in committee
1 of 4 stages cleared
Introduction
Dec 2021
Committee Review
Floor Vote
President
Introduced Dec 1, 2021
Last action Dec 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Dec 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Dec 1, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Dec 1, 2021
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6101
Scope: US
Hi! I can help you understand HR 6101. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline